“genzyme” Archives

in
Entry Author Date Location
Bio Leaders Mourn Passing of Genzyme Exec, Orphan Drug Innovator Termeer 05/14/17 Boston
Stalled or Rising Momentum? New York Wrestles With Its Biotech Future 05/10/17 New York
Bio Roundup: Gottlieb Talks Vax, Acorda’s Axe, Adams, 23andMe & More 04/07/17 National
Boston Startup Exit Data Show Region’s Shift From Tech to Healthcare 04/04/17 Boston
At Arrakis, Gilman Teams With Biogen Vets to Target RNA With Pills 02/27/17 Boston
Voyager’s Gene Therapy for Parkinson’s Shows Promise in Small Study 12/07/16 Boston
Amicus Shares Fall On Another Bump in Rough Road To U.S. Fabry Nod 11/28/16 New York
Should We Rewrite the Human Genome? 11/28/16 Boston
Bio Roundup: CAR-T & Migraine Races, Intra-Cellular, Rockefeller & More 09/30/16 National
Amylyx Nabs $5M to Take Aim at Nerve Cell Death in ALS Patients 08/22/16 Boston
Audentes Prices $75M IPO As Gene Therapy Eyes First U.S. Approval 07/20/16 San Francisco
Alnylam Advances RNAi Drug Results After Two Years of Treatment 07/01/16 Boston
Vedanta Nabs $50M To Expand Microbiome Into Immune-Boosting Therapies 06/06/16 Boston
Near-Term FDA Nod Unlikely For Duchenne Drug After Negative Vote 04/25/16 Boston
For San Antonio’s Consideration: A Biotech Incubator and Accelerator 04/08/16 Texas
At Long Last, First Drug Approval in Sight for Amicus 04/01/16 New York
East Coast Bio Roundup: PCSK9 Battle, NYU Startups, Blueprint & More 03/17/16 Boston
Proteostasis Cuts Price But Heads to Nasdaq After $50M IPO 02/11/16 Boston
Flint’s Water, Wicab, & New Leaders: This Week’s Wisconsin Watchlist 02/05/16 Wisconsin
Seeking A Fresh Start in Gene Therapy, Avalanche Merges With Annapurna 02/01/16 San Francisco
Boston Tech Scene Gains Big Anchor Tenant in General Electric 01/13/16 Boston
WaVe, Voyager Get $170M Combined in Biotech’s Latest IPO Tests 11/11/15 Boston
Voyager Charts an IPO Course Amid Choppy Biotech Waters 10/11/15 Boston
East Coast Biotech Roundup: Forum, Neon, Sarepta, Accelerator & More 10/02/15 Boston
In 2015, U-M Tech Transfer Topped Record-Breaking 2014 Numbers 09/22/15 Detroit Ann Arbor
American Copycats: Can Biosimilars Catch On And Cut Costs In U.S.? 09/15/15 National
East Coast Biotech Roundup: X4, Rgenix, Alnylam, Intellia & More 09/04/15 Boston
Ragan Reunites Ex-Genzymers at X4 Pharma to Battle Cancer 09/01/15 Boston
Stealthy X4 Pharma, Aided by Termeer, Other Ex-Genzymers, Nabs $37M+ 09/01/15 Boston
Drug Discovery in Seattle 2015: An Updated History 08/03/15 Seattle
Page 1 of 17 next page »